Ovarian cancer in Iranian women, a trend analysis of mortality and incidence

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 24, 2014, Pages 10787-10790

  Sharifian, Abdolhamid ^a   Pourhoseingholi, Mohamad Amin ^a   Norouzinia, Mohsen ^a   Vahedi, Mohsen ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Incidence; Iran; Mortality; Ovarian cancer; Trend analysis

Indexed keywords

ADOLESCENT; ADULT; AGE; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; IRAN; MIDDLE AGED; MORTALITY; OVARIAN NEOPLASMS; PROGNOSIS; REGISTER; SURVIVAL RATE; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; DEMOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; IRAN; MIDDLE AGED; MORTALITY; OVARIAN NEOPLASMS; PROGNOSIS; REGISTRIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84922998484     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.24.10787     Document Type: Article

References (29)

1. Akbari ME, Khayamzadeh M (2008). Incidence, mortality and burden of cancers in Iran. In: Akbari ME, editor. Iran cancer report. 1st ed. Tehran: Cancer Res Center, Shahid Beheshti university of medical sciences, 95-125.
2. Arab M, Khayamzadeh M, Mohit M, et al (2009). Survival of ovarian cancer in Iran: 2000-2004. Asian Pac J Cancer Prev, 10, 555-8.
3. Arab M, Khayamzadeh M, Tehranian A, et al (2010). Incidence rate of ovarian cancer in Iran in comparison with developed countries. Indian J Cancer, 47, 322-7.
4. Arab M, Noghabaei G, Kazemi SN (2014). Comparison of crude and age-specific incidence rates of breast, ovary, endometrium and cervix cancers in Iran, 2005. Asian Pac J Cancer Prev, 15, 2461-4.
5. Bhurgri Y, Shaheen Y, Kayani N, et al (2011). Incidence, trends and morphology of ovarian cancer in Karachi (1995-2002). Asian Pac J Cancer Prev, 12, 1567-71.
6. Burnet NG, Jefferies SJ, Benson RJ, et al (2005). Years of life lost (YLL) from cancer is an important measure of population burden - and should be considered when allocating research funds. Br J Cancer, 92, 241-5.
7. Hirabayashi Y, Marugame T (2009). Comparison of time trends in ovary cancer mortality (1990-2006) in the world, from the WHO Mortality Database. Jpn J Clin Oncol, 39, 860-1.
8. Hanna L, Adams M (2006). Prevention of ovarian cancer. Best Pract Res Clin Obstet Gynaecol, 20, 339-62.
9. Islamic Repulic of Iran (2009). Ministry of health and medical education. center for disease control & prevention. noncommunicable deputy. cancer office. Iranian An Natl Cancer Registrat Report.
10. Janssen-Heijnen ML, Houterman S, Lemmens VE, et al (2005). Age and co-morbidity in cancer patients: a population-based approach. Cancer Treat Res, 124, 89-107.
11. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
12. Lope V, Pollan M, Perez-Gomez B, et al (2008). Municipal distribution of ovarian cancer mortality in Spain. BMC Cancer, 8, 258.
13. Li DP, Du C, Zhang ZM, et al (2014). Breastfeeding and ovarian cancer risk: a systematic review and meta-analysis of 40 epidemiological studies. Asian Pac J Cancer Prev, 15, 4829-37.
14. Lowe KA, Chia VM, Taylor A, et al (2013). An international assessment of ovarian cancer incidence and mortality. Gynecol Oncol, 130, 107-14.
15. Lukanova A, Kaaks R (2005). Endogenous hormones and ovarian cancer: Epidemiology and current hypothesis. Cancer Epidemiol Biomarkers Prev, 14, 98-107.
16. Menon U (2012). Ovarian cancer screening has no effect on disease-specific mortality. Evid Based Med, 17, 47-8.
17. Marugame T, Hirabayashi Y (2007). Comparison of time trends in ovary cancer incidence (1973-1997) in East Asia, Europe, and the USA, from cancer incidence in five continents vols IV VIII. Jpn J Clin Oncol, 37, 802-3.
18. Moghimi-Dehkordi B, Safaee A, Vahedi M (2013). Overweight and obesity and related factors in urban Iranian population aged between 20 to 84 years. Ann Med Health Sci Res, 3, 171-6.
19. st edition. Tehran: Ministry Health.
20. st edition. Tehran: Ministry Health.
21. st edition. Tehran: Ministry Health.
22. National cancer institute (2005). SEER cancer statistics review (1975-2002). Ovarian epithelial cancer (PDG): treatment-health professionals. J National Cancer Institute. Vol 98.
23. Parkin DM, Bray F, Ferlay J, et al (2001). Estimating the world cancer burden: GLOBOCAN 2000. Int J Cancer, 94, 153-6.
24. Permuth-Weg J, Seliers T (2009). Epidemiology of ovarian cancer. In M. Verme (ed). Methods of Molecular Biology. Cancer Epidemiology, Vol 427; Humana Press.
25. Salehi F, Dunfield L, Phillips KP, et al (2008). Risk factors for ovarian cancer: an overview with emphasis on hormonal factors. J Toxicol Environ Health B Crit Rev, 11, 301-21.
26. Sant M, Aareleid T, Berrino F, et al (2003). EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol, 14, 61-118.
27. U.S. Preventive Services Task Force (2013). Screening for ovarian cancer: reaffirmation recommendation statement. Am Fam Physician, 87, Online.
28. Wang B, Liu SZ, Zheng RS, et al (2014). Time trends of ovarian cancer incidence in China. Asian Pac J Cancer Prev, 15, 191-3.
29. Zhou Y, Irwin ML, Risch HA (2011). Pre- and post-diagnosis body mass index, weight change, and ovarian cancer mortality. Gynecol Oncol, 120, 209-13.